z-logo
open-access-imgOpen Access
Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia
Author(s) -
Steven Pennock,
Leo A. Kim,
Andrius Kazlauskas
Publication year - 2016
Publication title -
molecular and cellular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.14
H-Index - 327
eISSN - 1067-8824
pISSN - 0270-7306
DOI - 10.1128/mcb.01019-15
Subject(s) - biology , vascular endothelial growth factor , angiogenesis , kinase insert domain receptor , microbiology and biotechnology , growth factor , platelet derived growth factor receptor , vascular endothelial growth factor a , hypoxia (environmental) , growth factor receptor , receptor , cancer research , hypoxia inducible factors , vascular endothelial growth inhibitor , vascular endothelial growth factor b , platelet derived growth factor , vegf receptors , signal transduction , biochemistry , chemistry , organic chemistry , oxygen , gene
Vascular endothelial cell growth factor A (VEGF) is a biologically and therapeutically important growth factor because it promotes angiogenesis in response to hypoxia, which underlies a wide variety of both physiological and pathological settings. We report here that both VEGF receptor 2 (VEGFR2)-positive and -negative cells depended on VEGF to endure hypoxia. VEGF enhanced the viability of platelet-derived growth factor receptor α (PDGFRα)-positive and VEGFR2-negative cells by enabling indirect activation of PDGFRα, thereby reducing the level of p53. We conclude that the breadth of VEGF's influence extends beyond VEGFR-positive cells and propose a plausible mechanistic explanation of this phenomenon.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom